All posts by: Michael Zand

About Michael Zand

Novartis files CAR-T therapy in US, with swift review – PMLiVE

Continue reading

2017-03-31 NEWS

Novartis files CART therapy in US, with swift review
PMLiVE
In CAR-T therapy, patients’ cells are harvested and modified so they are more likely to seek out and destroy cancer cells expressing a particular antigen, in this case CD19. Once reprogrammed, the T cells are infused back into the patient in order to

and more »

Continue reading

2017-03-31 NEWS

VIDEO: Immunotherapy research only at ‘tip of the iceberg’
Healio
NEW YORK — Jason J. Luke, MD, FACP, assistant professor of medicine at The University of Chicago Medicine, discussed the future of immunotherapies for the treatment of melanoma and other cancers at HemOnc Today Melanoma and Cutaneous …

Continue reading

2017-03-31 NEWS

Philly.com

Inovio And Collaborators Receive NIH Grant To Evaluate HIV Immunotherapy PENNVAX®-GP’s Ability To Induce …
Clinical Leader
This is a two-step clinical study in HIV-positive subjects to assess Inovio’s HIV immunotherapy PENNVAX-GP with INO-9012 (an IL-12 immune activator) alone and with the addition of a PD-1 checkpoint inhibitor. All trials will be randomized, double-blind
Inovio Pharmaceutical’s DNA vaccine will be tested in patients with HIVPhilly.com
Immune Check Activators Market — Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024Medgadget (blog)

all 3 news articles »

Continue reading

2017-03-31 NEWS

Katelyn’s sight: Stem cell treatments give TX family hope
KSLA-TV
“We’re trying to go to Thailand, we’re trying to get stem cells to help grow that optic nerve where, hopefully, one day she’ll be able to picture that image and have eyesight,” said Josh Yelvington, Katelyn’s dad. Last year, Katelyn and her parents